Hereditary hemorrhagic telangiectasia

Jonathan N. Berg, Anette Drøhse Kjeldsen

Publikation: Kapitel i bog/rapport/konference-proceedingKapitel i bogForskningpeer review

Abstrakt

Hereditary hemorrhagic telangiectasia is an autosomal dominant vascular disorder. It is characterized by mucocutaneous telangiectases, recurrent epistaxis, gastrointestinal bleeding, and arteriovenous malformations (AVMs) in the lungs, brain, and liver. It is caused by mutations in genes involved in serine‐threonine kinase signaling, ENG (endoglin), ACVRL1 (activin receptor‐like kinase 1), and SMAD4. Each of these is associated with a distinctive sub‐phenotype. Apart from symptomatic treatment of associated hemorrhage, it is essential to screen for and treat pulmonary arteriovenous malformations to avoid paradoxical embolic complications, which are a major cause of morbidity and mortality.
OriginalsprogEngelsk
TitelCassidy and Allanson's Management of Genetic Syndromes
RedaktørerJohn C. Carey, Agatino Battaglia, David Viskochil, Suzanne B. Cassidy
ForlagWiley
Publikationsdato2021
Udgave4.
Sider475-486
Kapitel30
ISBN (Trykt)9781119432678
ISBN (Elektronisk)9781119432692
DOI
StatusUdgivet - 2021

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hereditary hemorrhagic telangiectasia'. Sammen danner de et unikt fingeraftryk.

Citationsformater